RT Journal Article
SR Electronic
T1 The Association of Alpha Globin Gene Copy Number with Exhaled Nitric Oxide in a Cross-sectional Study of Healthy Black Adults
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.10.09.22280804
DO 10.1101/2022.10.09.22280804
A1 Ruhl, A. Parker
A1 Jackson, Jarrett M.
A1 Carhuas, Carlos J.
A1 Niño de Rivera, Jessica G.
A1 Fay, Michael P.
A1 Weinberg, J. Brice
A1 Que, Loretta G.
A1 Ackerman, Hans C.
YR 2023
UL http://medrxiv.org/content/early/2023/11/10/2022.10.09.22280804.abstract
AB Introduction The genetic determinants of fractional exhalation of nitric oxide (FeNO), a marker of lung inflammation, are understudied in Black individuals. Alpha globin (HBA) restricts nitric oxide signaling in arterial endothelial cells via interactions with nitric oxide synthase (NOS); however, its role in regulating the release of NO from respiratory epithelium is less well understood. We hypothesized that an HBA gene deletion, common among Black individuals, would be associated with higher FeNO.Methods Healthy Black adults were enrolled at four study sites in North Carolina from 2005-2008. FeNO was measured in triplicate using a nitric oxide analyzer. The −3.7 kb HBA gene deletion was genotyped using droplet digital PCR on genomic DNA. The association of FeNO with HBA copy number was evaluated using multivariable linear regression employing a linear effect of HBA copy number and adjusting for age, sex, and serum IgE levels. Post-hoc analysis employing a recessive mode of inheritance was performed.Results 895 individuals were in enrolled in the study and 720 consented for future genetic research; 643 had complete data and were included in this analysis. Median (25th, 75th) FeNO was 20 (13, 31) ppb. HBA genotypes were: 30 (4.7%) -a/-a, 197 (30.6%) -a/aa, 405 (63%) aa/aa, and 8 (1.2%) aa/aaa. Subjects were 35% male with median age 20 (19, 22) years. Multivariable linear regression analysis revealed no association between FeNO and HBA copy number (β = −0.005 [95% CI: −0.042, 0.033], p=0.81). In the post-hoc sensitivity analysis, homozygosity for the HBA gene deletion was associated with higher FeNO (β = 0.107 [95% CI 0.003, 0.212]; p = 0.045)Conclusion We found no association between HBA copy number and FeNO using a prespecified additive genetic model. However, a post hoc recessive genetic model found FeNO to be higher among subjects homozygous for the HBA deletion.KEY MESSAGESWhat is already known on this topic – The alpha subunit of hemoglobin restricts the release of nitric oxide from vascular endothelial cells, but alpha globin’s role in restricting exhaled nitric oxide is less well understood.What this study adds – We examined the association between fractional exhaled nitric oxide and deletion of the alpha globin gene, a frequent genetic polymorphism among people with African or Asian ancestry. We found that healthy Black individuals who were homozygous for the alpha globin gene deletion had higher fractional exhaled nitric oxide, consistent with alpha globin’s role as a nitric oxide restrictor.How this study might affect research, practice or policy – An alpha globin gene deletion, commonly found among Black individuals, may increase fractional exhaled nitric oxide. Whether this changes the normal range of fractional exhaled nitric oxide for Black individuals or impacts the risk of developing asthma requires further study.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe original study was supported by project ES011185 from the National Institute of Environmental Health Sciences; and MO1-RR-30 from the National Center for Research Resources, Clinical Research Centers Program, National Institutes of Health. The current analysis was supported in part by the Divisions of Intramural Research, National Institute of Allergy and Infectious Diseases project AI001150 (A.P.R., J.M.J, C.M.C, J.G.N., M.P. F., H.C.A), National Heart, Lung, and Blood Institute (NHLBI) project HL006196 (A.P.R., H.C.A.). This work was also funded in part by NHLBI grants NIH R01-HL107590 and R01HL153641 (L.G.Q.) and the Durham VA Medical Center Research Service (J.B.W.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIAID or NHLBI. The content of this publication does not necessarily reflect the view or policy of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the government. The interpretation and reporting of these data are the responsibility of the author(s) and in no way should be seen as an official policy or interpretation of the U.S. government.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All participants provided oral and written informed consent with approval from the Duke University Institutional Review Board.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDeidentified data and statistical code from this article will be available to researchers. Data can be obtained upon reasonable request by contacting the corresponding author.